Evaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19

Basit Öğe Kaydı
dc.contributor.authorMermutluoglu, Cigdem
dc.contributor.authorDursun, Recep
dc.contributor.authorAktar, Fesih
dc.contributor.authorDayan, Saim
dc.contributor.authorCelen, Mustafa Kemal
dc.contributor.authorKadiroglu, Ali Kemal
dc.contributor.authorInci, Erdal
dc.date.accessioned2024-04-24T17:20:58Z
dc.date.available2024-04-24T17:20:58Z
dc.date.issued2022
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroduction: This study aims to research the effects of hematological and inflammatory parameters on the prognosis of COVID-19 disease and Methodology: One hundred and eighty-six patients with COVID-19 and a control group consisting of 187 healthy individuals were included in the study. Hematological variables and inflammatory parameters of the patients were recorded on the first and the fifth days of hospitalization. Results: White blood cell count, lymphocyte count, and platelet count were statistically lower, and mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) levels were higher in the patient group compared to the control group. It was observed that the neutrophil count and MPV level were lower, and the platelet count and ferritin level were statistically higher on the fifth day of follow-up compared to the admission day. In contrast, there was a significantly positive correlation between the duration of hospitalization and the fifth day D-dimer (r = 0.546, p < 0.001) and ferritin (r = 0.568, p < 0.001); in addition, there was a negative correlation between the duration of hospitalization and admission day lymphocyte count and the fifth-day lymphocyte count. Conclusions: Increased levels of ferritin and D-dimer, and decreased count of lymphocytes are among the important factors affecting the duration of hospitalization for COVID-19 patients. Furthermore, we think that neutrophil count and MPV levels are low, and platelet count and ferritin levels are high during the disease. Therefore, these parameters can be used as prognostic indicators of the disease.en_US
dc.identifier.doi10.3855/jidc.14341
dc.identifier.endpage1569en_US
dc.identifier.issn1972-2680
dc.identifier.issue10en_US
dc.identifier.pmid36332208
dc.identifier.scopus2-s2.0-85141890758
dc.identifier.scopusqualityQ2
dc.identifier.startpage1564en_US
dc.identifier.urihttps://doi.org/10.3855/jidc.14341
dc.identifier.urihttps://hdl.handle.net/11468/19321
dc.identifier.volume16en_US
dc.identifier.wosWOS:000882494600004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherJ Infection Developing Countriesen_US
dc.relation.ispartofJournal of Infection in Developing Countries
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectKey Wordsen_US
dc.subjectCovid-19en_US
dc.subjectInfectionen_US
dc.subjectMarkersen_US
dc.subjectPandemicen_US
dc.titleEvaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19en_US
dc.titleEvaluation of inflammatory and hematological parameters in patients diagnosed with COVID-19
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu